RSV infection in adults ≥65 is linked to rare but elevated Guillain-Barré syndrome risk, particularly in those aged ≥75 years ...

Vaccine uptake may not be much better during the 2024–25 respiratory virus season. Fewer than two in five (38%) eligible recipients plan to get an RSV vaccine, according to a survey conducted in ...

The RSV vaccine is specifically created and approved for administration in older adults. Back in March, the FDA recommended ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A 5-percentage-point increase in vaccine uptake could avert over 222,000 LRTD ...

A robust antibody response was found in patients in residents of long-term care facilities who were given the respiratory syncytial virus (RSV) vaccine. RSV is a major respiratory infection that ...

Oct. 3, 2024 -- Respiratory Syncytial Virus (RSV) is often thought of as a childhood illness, but it poses a significant threat to older adults as well. According to the CDC, RSV infected ...

Lo que las personas mayores deben saber esta temporada de RSV (StatePoint) Each year, up to 160,000 older adults living in the United States are hospitalized and as many as 10,000 die due to ...

RSV hospitalization rates in older adults reached 58.3 per 100,000 in winter 2023-24, nearly half the rate of influenza at 114.6 per 100,000. Mortality and clinical outcomes were comparable between ...

The researchers found that RSV vaccination was 82.3% effective in protecting against hospital admission for participants with ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research. The ...

Oct. 30—(StatePoint) Each year, up to 160,000 older adults living in the United States are hospitalized and as many as 10,000 die due to respiratory syncytial virus (RSV). RSV is a highly contagious ...